These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15934594)

  • 21. Cardiology patient page. Beta-adrenergic blockers.
    Frishman WH
    Circulation; 2003 May; 107(18):e117-9. PubMed ID: 12742970
    [No Abstract]   [Full Text] [Related]  

  • 22. [Beta-blockers in the treatment of heart failure].
    Komajda M; Salloum J; Lechat P; Grosgogeat Y
    Presse Med; 1990 Feb; 19(5):213-6. PubMed ID: 1968634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
    Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
    Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular protection using beta-blockers: a critical review of the evidence.
    Bangalore S; Messerli FH; Kostis JB; Pepine CJ
    J Am Coll Cardiol; 2007 Aug; 50(7):563-72. PubMed ID: 17692739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
    Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-blockers: acting in the brain but healing the heart.
    Gourine AV; Spyer KM; Gourine A
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):913-5. PubMed ID: 18666840
    [No Abstract]   [Full Text] [Related]  

  • 27. Pilot study to assess the influence of beta-blockade on mitral regurgitant volume and left ventricular work in degenerative mitral valve disease.
    Stewart RA; Raffel OC; Kerr AJ; Gabriel R; Zeng I; Young AA; Cowan BR
    Circulation; 2008 Sep; 118(10):1041-6. PubMed ID: 18725484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of metoprolol on systolic and diastolic function in children with heart failure.
    Ghader FR; Abaskhanian ZA
    Pak J Biol Sci; 2009 Mar; 12(5):451-4. PubMed ID: 19579987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardioprotection with beta-blockers: myths, facts and Pascal's wager.
    Messerli FH; Bangalore S; Yao SS; Steinberg JS
    J Intern Med; 2009 Sep; 266(3):232-41. PubMed ID: 19702791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
    Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J;
    J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expert Consensus document on beta-adrenergic receptor blockers].
    López-Sendón J; Swedberg K; McMurray J; Tamargo J; Maggioni AP; Dargie H; Tendera M; Waagstein F; Kjekshus J; Lechat P; Torp-Pedersen C;
    Rev Esp Cardiol; 2005 Jan; 58(1):65-90. PubMed ID: 15680133
    [No Abstract]   [Full Text] [Related]  

  • 32. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
    van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Beta-blockers in chronic heart insufficiency. The Danish Society of Cardiology].
    Nielsen-Kudsk JE
    Ugeskr Laeger; 2000 Mar; 162(12):1713. PubMed ID: 10745660
    [No Abstract]   [Full Text] [Related]  

  • 34. Beta-blockers: new standard therapy for heart failure.
    Pritchett AM; Redfield MM
    Mayo Clin Proc; 2002 Aug; 77(8):839-45; quiz 845-6. PubMed ID: 12173717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Beta blockers in cardiac insufficiency. When, how much and which substance].
    Wuttke H; Rau T; Eschenhagen T
    Med Monatsschr Pharm; 2004 Dec; 27(12):415-20; quiz 421-2. PubMed ID: 15646690
    [No Abstract]   [Full Text] [Related]  

  • 36. Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction.
    Hamdani N; Paulus WJ; van Heerebeek L; Borbély A; Boontje NM; Zuidwijk MJ; Bronzwaer JG; Simonides WS; Niessen HW; Stienen GJ; van der Velden J
    Eur Heart J; 2009 Aug; 30(15):1863-72. PubMed ID: 19487234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heart failure, atrial fibrillation, and beta-blockers.
    van Veldhuisen DJ; Crijns HJ; van den Berg MP
    Eur Heart J; 2006 Jan; 27(2):247. PubMed ID: 16311238
    [No Abstract]   [Full Text] [Related]  

  • 38. Beta-blockers and heart failure in older people.
    Le Couteur DG; Bailey L; Naganathan V
    Eur Heart J; 2006 Apr; 27(7):887-8; author reply 888-9. PubMed ID: 16478748
    [No Abstract]   [Full Text] [Related]  

  • 39. Experience with beta-blockers in long term management of peripartum cardiomyopathy.
    Mohsin K; Akhtar N
    J Ayub Med Coll Abbottabad; 2004; 16(2):80-1. PubMed ID: 15455627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta-Blocker therapy for congestive heart failure: clinical considerations.
    Kamath SA; Yancy CW
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):12-20. PubMed ID: 19667706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.